Endoscopy
DOI: 10.1055/a-1237-5221
Innovations and brief communications

COVID-19 and endoscopic management of superficial gastrointestinal neoplastic lesions: a multinational cross-sectional survey

Marta Rodríguez-Carrasco
1  Department of Gastroenterology, Portuguese Oncology Institute of Porto, Porto, Portugal
,
Eduardo Albéniz
2  Endoscopy Unit and Gastroenterology Department, Complejo Hospitalario de Navarra, Navarrabiomed Biomedical Research Center, UPNA, IdiSNA, Pamplona, Spain
,
Pradeep Bhandari
3  Department of Gastroenterology, Queen Alexandra Hospital, Portsmouth, UK
,
Torsten Beyna
4  Department of Gastroenterology, Evangelisches Krankenhaus, Düsseldorf, Germany
,
Michael J. Bourke
5  Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, Australia
,
Ahyeon Min
5  Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, Australia
,
Philip W. Y. Chiu
6  Endoscopy Center, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China
,
Simon Chu
6  Endoscopy Center, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China
,
Hon Chi Yip
6  Endoscopy Center, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China
,
Pierre H. Deprez
7  Department of Hepato-Gastroenterology, Cliniques universitaires St-Luc, Université Catholique de Louvain, Brussels, Belgium
,
Fabian Emura
8  EmuraCenter Latinoamérica, Bogota, Colombia
9  Gastroenterology Division, Universidad de La Sabana, Chia, Colombia
,
Alessandro Repici
10  Department of Gastroenterology, Humanitas Research Hospital, Humanitas University, Rozzano, Milan, Italy
,
Noriko Suzuki
11  Wolfson Department of Endoscopy, St Mark's Hospital, London, UK
,
Naohisa Yahagi
12  Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan
,
Yoko Kubosawa
12  Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan
,
Cesare Hassan
13  Department of Gastroenterology, Nuovo Regina Margherita Hospital, Rome, Italy
,
Mário Dinis-Ribeiro
1  Department of Gastroenterology, Portuguese Oncology Institute of Porto, Porto, Portugal
14  MEDCIDS - Department of Community Medicine, Health Information and Decision, Faculty of Medicine, University of Porto, Porto, Portugal
› Author Affiliations

Abstract

Introduction We aimed to report the impact of the pandemic lockdown period on the treatment and prognosis of superficial gastrointestinal neoplastic lesions.

Methods A survey was completed by 11 centers from four continents regarding postponements during the early lockdown period of the pandemic, and the same period in 2019.

Results In 2020, 55 % of the scheduled procedures were deferred, which was 11 times higher than in 2019; the main reasons were directly related to COVID-19. In countries that were highly affected, this proportion rose to 76 % vs. 26 % in those where there was less impact. Despite the absolute reduction, the relative distribution in 2019 vs. 2020 was similar, the only exception being duodenal lesions (affected by a 92 % reduction in mucosectomies). Although it is expected that the majority of postponements will not affect the stage (based on the results from biopsies and/or endoscopic appearance), 3 % of delayed procedures will probably require surgery.

Conclusions The lockdown period caused by the SARS-CoV-2 pandemic led to a substantial reduction in the number of endoscopic resections for neoplastic lesions. Nevertheless, based on clinical judgment, the planned median delay will not worsen the prognosis of the affected patients.



Publication History

Received: 23 May 2020

Accepted: 11 August 2020

Publication Date:
11 August 2020 (online)

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany